Andrew Mendiola shared his research and his Bike MS experience at the National Multiple Sclerosis Leadership Conference

November 15, 2019

 

Mark Petersen is awarded an NIH/NINDS fellowship entitled, “Fibrinogen-Mediated Mechanisms of Preterm Infant Brain Injury.”

November 10, 2019

$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease

October 31, 2019

Click here to read the full article.

Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.

 

New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease

October 8, 2019

Click here to read full article.

Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.

Momentum, NMSS Magazine – A big part of the MS puzzle

July 11, 2019

Click here to view article.

Momentum_Interview 2019

Meet Gladstone: Andrew Mendiola

June 21, 2019

Andrew is a postdoctoral scholar in Katerina Akassoglou’s lab. He grew up in Marion, Texas, a small town in-between Austin and San Antonio. Before joining Gladstone, he completed a PhD in cellular and molecular biology with a concentration in immunology at The University of Texas at San Antonio.

Click here to read full article.

MS News Today – Need to Know: What Is the Blood Brain Barrier?

June 13, 2019

Click here to read full article.

Andrew Mendiola Receives an Oral Presentation Award at the Aegean Conference on Innate Immunity – Rhodes, Greece

June 12, 2019

Andrew Mendiola Receives a Best Poster Award at the Gladstone Institutes Scientific Retreat 2019

May 22, 2019

Congratulations to Andrew Mendiola in our lab, and all others, for receiving Best Poster Awards at the Gladstone Institutes Scientific Retreat 2019!